[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100567799":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":29,"locations":38,"responsibleParty":80,"collaborators":83,"id":89,"slug":90,"hasResults":91,"nctId":92,"briefTitle":93,"officialTitle":94,"acronym":21,"eligibilityCriteria":95,"healthyVolunteers":96,"sex":97,"minAge":98,"maxAge":99,"enrollmentInfo":100,"targetDuration":18,"studyType":103,"phases":104,"briefSummary":107,"conditions":108,"keywords":111,"overallStatus":41,"whyStopped":18,"lastUpdateSubmitDate":119,"lastUpdatePostDateStruct":120,"startDateStruct":123,"completionDateStruct":125,"leadSponsor":127,"locationsCount":128},{"fullName":5,"class":6},"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Intervention group","EXPERIMENTAL","Employers randomized to the intervention group will get a personal link to the MiLES intervention.",[13],"Other: MiLES",{"label":15,"type":16,"description":17,"interventionNames":18},"Control group","NO_INTERVENTION","The employees randomized to the control group will receive \"care as usual\" from their employer, as well as from their reintegration consultant or occupational physician. Their employer will not have access to the MiLES intervention during the study period. However, they will gain access for 6 months following a waiting-list period of 12 months.",null,[20],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":18},"MiLES","The MiLES intervention is an open access website, accessible via an URL, but not traceable through any online search engine during the study period. Tailored for specific preferences and needs of different employees with cancer, the MiLES intervention consists of interactive videos, conversation checklists, tips and information regarding RTW guidance of employees with cancer, and an overview of involved stakeholders and relevant legislation. The MiLES intervention intends to optimize the RTW support the employer provides to the employee with cancer by enhancing the willingness and ability to implement the employer actions. The MiLES intervention focuses for example on fostering effective communication between the employer and employee, while disregarding assumptions based on previous experiences.",[9],[25],{"name":26,"affiliation":27,"role":28},"Sietske Tamminga, PhD","Amsterdam UMC, location AMC","PRINCIPAL_INVESTIGATOR",[30,35],{"name":31,"role":32,"phone":33,"phoneExt":18,"email":34},"Judith Mollet, MSc","CONTACT","+31205669111","milesonderzoek@amsterdamumc.nl",{"name":36,"role":32,"phone":33,"phoneExt":18,"email":37},"Michiel Greidanus, PhD","m.a.greidanus@amsterdamumc.nl",[39,51,58,65,73],{"facility":40,"status":41,"city":42,"state":18,"zip":18,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":18},"Arbo Unie","RECRUITING","Arnhem","Netherlands","NL",{"type":46,"coordinates":47},"Point",[48,49],5.91111,51.98,{"lat":49,"lon":48},{"facility":40,"status":41,"city":52,"state":18,"zip":18,"country":43,"countryCode":44,"cosmosGeoPoint":53,"geoPoint":57,"contacts":18},"Dordrecht",{"type":46,"coordinates":54},[55,56],4.67361,51.81,{"lat":56,"lon":55},{"facility":40,"status":41,"city":59,"state":18,"zip":18,"country":43,"countryCode":44,"cosmosGeoPoint":60,"geoPoint":64,"contacts":18},"Hengelo",{"type":46,"coordinates":61},[62,63],6.79306,52.26583,{"lat":63,"lon":62},{"facility":66,"status":41,"city":67,"state":18,"zip":18,"country":43,"countryCode":44,"cosmosGeoPoint":68,"geoPoint":72,"contacts":18},"Re-turn","Utrecht",{"type":46,"coordinates":69},[70,71],5.12222,52.09083,{"lat":71,"lon":70},{"facility":40,"status":41,"city":74,"state":18,"zip":18,"country":43,"countryCode":44,"cosmosGeoPoint":75,"geoPoint":79,"contacts":18},"Zeeland",{"type":46,"coordinates":76},[77,78],5.67639,51.6975,{"lat":78,"lon":77},{"type":28,"investigatorFullName":81,"investigatorTitle":82,"investigatorAffiliation":27,"oldNameTitle":18,"oldOrganization":18},"Michiel Greidanus","Postdoc researcher",[84,86,88],{"name":85,"class":6},"Dutch Cancer Society",{"name":66,"class":87},"UNKNOWN",{"name":40,"class":87},"100567799","phase-2-enhancing-successful-return-to-work-of-employees-with-cancer-by-supporting-employers-miles-intervention-100567799",false,"NCT06672887","Enhancing Successful Return to Work of Employees With Cancer, by Supporting Employers (MiLES Intervention)","Effectiveness, Cost-effectiveness, and Return on Investment of the Web-based MiLES Intervention Targeted at Employers, to Enhance Successful Return to Work of Employees With Cancer","Inclusion criteria employees with cancer:\n\n* Diagnosed with cancer \\<2 years earlier;\n* Being of working age (between 18-65 years, considering the Dutch retirement age of 67 years, and the study's follow-up period of one year);\n* In paid employment with an employer;\n* Having either an occupational physician at the involved occupational health service or a reintegration consultant at the involved reintegration service (e.g. working for an organization that is affiliated with one of the settings of this study);\n* Currently fully or partly sick-listed (\\<2 years);\n* Able to understand and read Dutch for filling out questionnaires;\n* Having already informed their employer about their diagnosis of cancer, or intending to do so;\n* Not yet applied or planning to apply for an invalidity benefit under the WIA.\n\nInclusion criteria employers:\n\n* Supports and guides the participating employee with cancer during the period of sick leave and RTW. For example, as the direct supervisor or HR-manager;\n* Able to understand and read Dutch to be able to use the MiLES intervention and for filling out questionnaires;\n* Not yet familiar with the MiLES intervention.\n\nExclusion Criteria:\n\n\\- Employees with cancer and their employers must participate as a dyad. If one party in the dyad is unable or unwilling to participate, the other party cannot participate either.",true,"ALL","18 Years","65 Years",{"count":101,"type":102},140,"ESTIMATED","INTERVENTIONAL",[105,106],"PHASE2","PHASE3","The objective of this randomized controlled trial (RCT) is to evaluate the effectiveness of the MiLES intervention targeted at employers, on successful return to work (RTW) of employees with cancer, compared to care as usual (CAU).\n\nSecundary objectives are:\n\n* To evaluate the cost-effectiveness and return-on-investment of the MiLES intervention on successful RTW and quality of life, compared to CAU.\n* To evaluate the effectiveness of the MiLES intervention on several outcome measures on the level of the employee with cancer (time to RTW, quality of life, quality of working life, received work-related support, and satisfaction with work-related support), and the level of the employer (self-efficacy in providing RTW support, and satisfaction with the RTW process).\n\nParticipants will be 140 employer-employee with cancer dyads. All dyads will randomly be allocated to the intervention group, of which the employer will get unlimited access to the MiLES intervention, or to the control group in which CAU will be provided. The follow-up of this study will be 12 months.\n\nAlong with the RCT, a process evaluation using the UK Medical Research Council framework will also be conducted.",[109,110],"Cancer","Neoplasm",[112,113,114,115,116,117,118],"Cancer survivor","Employee with cancer","Employer","Return to work","Employment","Manager","Employee","2024-11-01",{"date":121,"type":122},"2024-11-04","ACTUAL",{"date":124,"type":122},"2023-12-18",{"date":126,"type":102},"2025-12",{"name":5,"class":6},5]